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Abstract Gliotoxin is produced by non-ribosomal peptide
synthesis and secreted from certain fungi, including Aspergil-
lus fumigatus. It is an epipolythiodioxopiperazine that
contains an intact disulphide bridge and is the focus of
intense research as a consequence of its negative immuno-
modulatory properties. Gliotoxin detection is generally
enabled by reversed-phase–high-performance liquid chroma-
tography (RP-HPLC), with absorbance detection (220–
280 nm), or liquid chromatography-mass spectrometry, yet
detection is not readily achievable by matrix-assisted laser
desorption ionisation–time-of-flight mass spectrometry
(MALDI-ToF MS). We have developed a single-pot deriva-
tisation strategy which uses sodium borohydride-mediated
reduction of gliotoxin followed by immediate alkylation of
exposed thiols by 5′-iodoacetamidofluorescein to yield a
stable product, diacetamidofluorescein-gliotoxin (GT-(AF)2),
of molecular mass 1103.931 Da ((M+H)+). This product is
readily detectable by RP-HPLC and exhibits a 6.8-fold
increase in molar absorptivity compared with gliotoxin,
which results in a higher sensitivity of detection (40 ng;
125 pmoL). GT-(AF)2 also fluoresces (excitation/emis-
sion, 492:518 nm). Unlike free gliotoxin, the product
(>800 fmol) is detectable by MALDI-ToF MS. Sporides-
min A can also be detected by RP-HPLC and MALDI-ToF
MS (>530 fmol) using this strategy. We also demonstrate
that the strategy facilitates detection of gliotoxin (mean±
SD=3.55±0.07 μg 100 μL−1; n=2) produced by A.
fumigatus, without the requirement for organic extraction
of culture supernatants and associated solvent removal.
GT-(AF)2 is also detectable (150 ng; 460 pmol) by thin-
layer chromatography.
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Introduction
Gliotoxin is secreted by Aspergillus fumigatus and other
fungi when grown in culture or during infection of a host
organism, where is can exert immunosuppressive effects
(Fig. 1) [1, 2]. It is an epipolythiodioxopiperazine (ETP)-
type toxin (326 Da) which contains a disulphide bridge of
unknown origin. This structural feature of gliotoxin plays a
highly significant role in mediating the virulence of A.
fumigatus [3, 4]. Gliotoxin is not immunogenic, and its
toxicity in mammalian cells is generally enabled by direct
inactivation of essential protein thiols, inhibition of
NADPH oxidase assembly, in addition to promotion of
redox cycling which leads to hydrogen peroxide formation
[1, 5–7]. Sporidesmin A (Fig. 1) is also an ETP-type
metabolite which contains a disulphide bridge and is
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produced by the animal disease-causing fungus, Pithomyces
chartarum [3].
The detection of fungal-specific peptide biomarkers such as
gliotoxin represents an emerging strategy for the reliable
diagnosis of fungal infection which, to date, has proved to be
extremely difficult [8, 9]. Gliotoxin detection is normally by
reversed-phase high-performance–liquid chromatography
(RP-HPLC) with UV absorbance detection (220–280 nm),
gas chromatography-mass spectrometry or liquid
chromatography-mass spectrometry (LC-MS) analysis [10–
13]. More specifically, gliotoxin detection following RP-
HPLC separation is usually carried out at 254 nm [10]. The
immunological detection of gliotoxin by ELISA has been
demonstrated, and here, the limit of detection was
10 μg mL−1 [14]. In addition, Lewis et al. showed that
gliotoxin was present in sera and lungs of mice suffering
from experimentally induced invasive aspergillosis by LC-
MS analysis [15]. These authors also demonstrated that
gliotoxin could be detected, by LC-MS, in cancer patients
with either proven or probable invasive aspergillosis [15].
Studies on gliotoxin biosynthesis, which have demon-
strated the role of the non-ribosomal peptide synthetase,
GliP, in mediating the initial step of gliotoxin formation,
have also deployed LC-MS to detect the presence and
absence of gliotoxin in wild-type and mutant (ΔgliP)
cultures from A. fumigatus [16]. Moreover, using a
chemical reduction and alkylation strategy, thiol and
disulphide absence has been confirmed in a gliotoxin-like
metabolite isolated from an A. fumigatus mutant deficient in
gliotoxin biosynthesis [17]. To date, matrix-assisted laser
desorption ionisation–time-of-flight mass spectrometry
(MALDI-ToF MS) has not been used for the detection of
gliotoxin, as matrix components can interfere with the
detection of low molecular mass metabolites and gliotoxin
fragments during ionisation, thereby rendering detection
impossible [16, 18].
The constituent disulphide bridge of gliotoxin can be
cleaved and converted to two thiol groups by reduction
with compounds such as Cleland’s reagent/dithiothreitol or
β-mercaptoethanol [19]. However, these low molecular
mass molecules cannot be removed by dialysis or gel
filtration from reduced gliotoxin, and their presence will
interfere with any subsequent chemical modification (e.g.,
alkylation) of exposed thiols. It has also been demonstrated
that glutathione-mediated reduction of gliotoxin is possible
but results in the formation of mixed disulphides [20, 21]
which would be refractory to subsequent modification
through blocked thiols. Alternative reducing agents com-
patible with post-reduction labelling are therefore required,
and Woodcock et al. have demonstrated that sodium
borohydride (NaBH4) can reduce both gliotoxin and
sporidesmin A [22].
In the present work, NaBH4 was used to reduce the
disulphide bridge of gliotoxin to generate thiol groups
which could react with 5′-iodoacetamidofluorescein (5′-
IAF) to yield a stable derivative. This reaction product is
detectable at higher sensitivity than unlabelled gliotoxin, by
RP-HPLC, and could also be detected by MALDI-ToF MS
and thin-layer chromatography analysis (TLC).
Materials and methods
Materials and reagents
All reagents were obtained from Sigma-Aldrich, Dorset,
UK, unless otherwise indicated. 5′-IAF was prepared in
dimethyl sulfoxide (DMSO) at 3–10 mg mL−1. NaBH4
(500 mM) was prepared in HPLC-grade water and used
within 30 min of preparation. A. fumigatus strains Af293
(wild-type) and ΔgliZ (a kind gift from Professor Nancy
Keller, University of Wisconsin-Madison), a binuclear
cluster domain transcription factor-deficient mutant incapable
of gliotoxin biosynthesis [23], were cultured as described
elsewhere [17, 24]. Sporidesmin A was purchased from
AgResearch (Hamilton, New Zealand).
Reduction and alkylation of gliotoxin under organic
or aqueous conditions
Solutions containing gliotoxin (100 μL; 100 μg mL−1
methanol; 30.6 nmoL gliotoxin) were prepared. To these
were added 2.5 μL 500 mM NaBH4 (1.2 μmol NaBH4),
followed by gentle mixing by vortexing and incubation for
60 min at room temperature (occasionally 50 mM NaBH4
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Fig. 1 A Gliotoxin, B sporidesmin A, and C proposed structure of
diacetamidofluorescein-gliotoxin (GT-(AF)2)
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was used as reductant, as indicated). Labelled sporidesmin
A was prepared under identical conditions. No NaBH4 was
added when the intact disulphide bridge of gliotoxin was
required (i.e. as negative control), and gliotoxin prepara-
tions were also independently reduced using 6 μL dithio-
threitol (DTT; 10 mM in deionised water), which contains
free thiol groups, for comparison with NaBH4 as reducing
agent. 5′-IAF (20 μL, 3 mg mL−1; 120 nmol) was added to
reduced or oxidised gliotoxin preparations (30.6 nmol),
followed by vortexing of the resultant mixtures briefly and
incubation for 40 min in the dark at room temperature prior
to HPLC analysis. Alkylation of reduced gliotoxin was also
undertaken as described above using excess iodoacetamide
(400 nmol) instead of 5′-IAF. Tris(2-carboxyethyl) phos-
phine hydrochloride (TCEP·HCl; Thermo Scientific) could
also be used as reducing agent (125 nmol per reaction) prior
to 5′-IAF-mediated alkylation.
RP-HPLC analysis of culture supernatants (48 h; adjust-
ed to pH 7.5 using 0.1 volume 1 MNa2HPO4 pH 7.5) of A.
fumigatus Af293, spiked with gliotoxin and following
NaBH4 (500 mM) reduction and subsequent labelling with
5′-IAF was also undertaken. Here, gliotoxin (327 μg mL−1;
50 μL) was added to 50 μL A. fumigatus culture super-
natants pH 7.5, followed by addition of 50 μL dimethyl
sulfoxide. Sodium borohydride (3.3 μL; 50 or 500 mM)
was then added followed by 10 μL 5′-IAF (10 mg mL−1).
Modification of endogenous gliotoxin in culture super-
natants, under aqueous conditions, via sodium borohydride
reduction and 5′-IAF labelling was undertaken as follows—
2.5 μL 500 mM NaBH4 and 20 μL 5′-IAF (3 mg mL
−1;
120 nmol) were added per 100 μL test specimen (A.
fumigatus culture supernatants, pH 7.5) and incubated
sequentially as indicated above. Endogenous gliotoxin
was also chloroform-extracted from A. fumigatus culture
supernatants and resuspended in methanol [17]. Extensive
assay validation and investigation included evaluation of
alternative chromatographic conditions to detect labelled
gliotoxin, compatibility with MALDI-ToF MS, sensitivity
of detection, reproducibility, reductive alkylation of glio-
toxin under aqueous conditions, sporidesmin A compatibil-
ity and TLC detection.
RP-HPLC analysis
Reversed-phase HPLC used solvent A 0.1% (v/v) trifluoro-
acetic acid in HPLC-grade water and solvent B 0.1% (v/v)
trifluoroacetic acid in 100% (v/v) acetonitrile. Chromatog-
raphy, using a C18 column (Agilent Zorbax Eclipse XDB-
C18; 5-μm particle size; 4.6×15 mm) was carried out using
an Agilent Series 1,200 HPLC system equipped with diode
array (DAD) and fluorescence detectors. Gradient HPLC
conditions (three) were as follows: method 1, 35–60%
solvent B over 6 min (Δ%B/min=4.0); method 2, 5–100%
solvent B over 20 min (Δ%B/min=4.75) or method 3, over
24 min (Δ%B/min=4.0) and were employed for gliotoxin,
reduced gliotoxin, and labelled gliotoxin separation followed
by absorbance detection (220 or 254 nm) plus fluorescence
detection (excitation, 492 nm; emission, 518 nm). Isocratic
conditions were always established prior to specimen injec-
tion and the column washed and re-equilibrated prior to
subsequent specimen injection. Sporidesmin A was similarly
analysed. Specimen injection volume was 20 μL, unless
otherwise noted, at a solvent flow rate of 1 mL min−1.
MALDI-ToF MS
Mass spectrometry was carried out using an Ettan™ MALDI-
ToF mass spectrometer (Amersham Biosciences (Europe)
GmbH, Freiburg, Germany). Specimens (0.5 μL), neat or
diluted up to 1/200 in 0.1% (v/v) trifluoroacetic acid, for mass
determination were layered upon 0.5 μL α-cyano-4-hydrox-
ycinnamic acid (5 mg 200 μL−1 50%(v/v) acetonitrile in 0.1%
(v/v) aqueous trifluoroacetic acid), previously deposited onto
mass spectrometry slides and allowed to dry prior to delayed
extraction, reflectron ToF analysis at 20 kV [24]. Internal
calibrants, angiotensin III and adrenocorticotropic hormone
fragments 18–39, were used to calibrate spectra.
Thin-layer chromatography analysis
TLC analysis of reduced and labelled gliotoxin, 5′-IAF
only, and unreduced gliotoxin in the presence of 5′-IAF was
performed. TLC analysis used Merck silica gel 60-F254
TLC plates (aluminium backed). Solvent systems were
dichloromethane/methanol (90:10; containing 100 μL acetic
acid per 10 mL) or dichloromethane/methanol (94:6). The
sample application volume was 1 μL. Images were obtained
using a Fluorescence Scanner (Typhoon Variable Mode
Imager; GE Healthcare) at excitation and emission wave-
lengths at 488 and 520 nm, respectively (sensitivity setting,
600 V; 50 μm pixel size).
Results
Alkylation of NaBH4-reduced gliotoxin enhances detection
NaBH4-mediated reduction enables the subsequent alkylation
of exposed thiols on gliotoxin using 5′-IAF; moreover,
removal of the reducing agent is not required prior to
alkylation. Figure 2a illustrates the formation of 5′-IAF-
labelled gliotoxin (retention time (RT)=5.18 min), following
RP-HPLC separation and detection at 254 nm. Unreacted 5′-
IAF is also visible upon chromatography (RT=4.66 min).
Labelled gliotoxin is not present when the disulphide bridge
of gliotoxin remains intact (in the absence of NaBH4) and
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therefore unavailable for alkylation (Fig. 2b). However, free
gliotoxin is evident in Fig. 2b (RT=4.35 min). Although the
amounts (10 μg) of gliotoxin initially present in reaction
mixtures were identical, absorbance of 5′-IAF labelled
gliotoxin (peak area (mean±SD)=8,772±606; n=3) was
enhanced relative to the unlabelled reduced or oxidised form
(peak area (mean±SD)=1,287±122; n=3). This observed
increase in A254nm of labelled gliotoxin is clearly due to an
increase in the molar extinction coefficient (ε) relative to free
gliotoxin and indicates a 6.8-fold increase in sensitivity of
detection for labelled, compared with free, gliotoxin detection.
The labelled form of gliotoxin also fluoresces, although it
appears that the quantum yield of the fluorescein component
is suppressed at the low pH conditions employed for RP-
HPLC (Fig. 2c). Here, fluorescently labelled gliotoxin is
detected at RT=5.20 min, and no fluorescently labelled
gliotoxin is evident without prior reduction (data not shown).
Thus, identification of labelled gliotoxin at 254 nm enhances
the specificity, as well as sensitivity, of the method over pre-
existing strategies for direct gliotoxin detection.
Modified gliotoxin is detectable by MALDI-ToF MS
Detection of gliotoxin by MALDI-ToF MS is confounded by
both small molecular size and ionisation-induced fragmenta-
tion, however, alkylation of gliotoxin results in a stable
molecular species readily detectable by MALDI-ToF MS.
Both thiol groups of reduced gliotoxin were covalently
alkylated by 5′-IAF to form a diacetamidofluorescein deriva-
tive of gliotoxin, confirmed by the appearance of a species of
m/z 1103.931 ((M+H)+) which corresponds precisely to the
protonated form of doubly acetamidofluorescein-labelled
gliotoxin (i.e. GT-(AF)2) (1102.93 Da), as determined by
MALDI-ToF MS analysis (Fig. 3). The proposed molecular
structure of GT-(AF)2 is shown in Fig. 1c. Reduction and 5′-
IAF treatment of a gliotoxin-deficient strain (A. fumigatus
ΔgliZ [23]) did not yield any GT-(AF)2, thereby confirming
the specificity of gliotoxin detection using this strategy (data
not shown). No product was detectable by MALDI-ToF MS
either in the absence of prior reduction or the absence of 5′-
IAF (data not shown). Gliotoxin was also labelled by
iodoacetamide-mediated alkylation, resulting in complete
disappearance of oxidised gliotoxin from solution; however,
no evidence of absorbance enhancement of alkylated glio-
toxin was apparent in this case (data not shown). Neither was
any molecular species of m/z 384.96 or 443.02, which would
correspond to the mass of mono- or diacetamido-gliotoxin,
respectively, detectable by MALDI-ToF MS. Thus, it appears
that only 5′-IAF, and not iodoacetamide, is a suitable agent to
stabilise gliotoxin for subsequent MALDI analysis.
Derivatised sporidesmin A detection by RP-HPLC
and MALDI-ToF MS
Sporidesmin A underwent NaBH4-mediated reduction and
was also subjected to alkylation. RP-HPLC analysis using
GT-(AF)2
5’-IAF A
B
C
GT-(AF)2
Fig. 2 RP-HPLC analysis of pure gliotoxin (Sigma-Aldrich) with A
and without B sodium borohydride-mediated reduction prior to 5′-IAF
labelling. A Gliotoxin+NaBH4+5′-IAF: Gliotoxin disulphide bridge
is reduced and SH groups (thiols) alkylated by 5′-IAF. The
fluorescently labelled form of gliotoxin (GT-(AF)2) was detectable at
254 nm with a retention time of 5.18 min as indicated in (A). B
Gliotoxin disulphide intact: No fluorescent labelling of gliotoxin
possible. Free gliotoxin (GT) is detectable at 254 nm with a retention
time of 4.35 min. Identical amounts of gliotoxin were present in each
assay, yet the labelled form exhibits higher absorbance, compared with
free gliotoxin, at 254 nm. C Fluorescence detection of labeled
gliotoxin following HPLC separation. Excitation and emission 492/
518 nm. Fluorescently labelled gliotoxin is evident at retention time of
5.20 min (slightly later than that for a 254 nm detection (5.18 min) as
the fluorescence detector was in series after DAD)
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method 1 demonstrated that reduction resulted in a shift in
retention time from 7.27 to 5.48 min (Fig. 4a, b) and that
sporidesmin A could be derivatised with 5′-IAF (only after
reduction) to yield a product, sporidesmin A-(AF)2, which
eluted at 7.96 min (Fig. 4c, d). Sporidesmin A-(AF)2
(>530 fmol) was detectable by MALDI-ToF MS, as
described for GT-(AF)2, as a charged species at m/z
1251.145, which corresponds precisely to the predicted
protonated mass of the derivative (Fig. 4e). No sporidesmin
A-(AF)2 was detectable without the presence of NaBH4 in
the reaction mixtures (data not shown).
NaBH4 is the preferred reductant for gliotoxin
Data in Fig. S1 (Electronic Supplementary Material)
illustrate that GT-(AF)2 is detectable at 254 nm with a
retention time of 15.24 min using either DTT (peak area
(mean±SD)=1,833±1,543; n=3) (Fig. S1a, Electronic
Supplementary Material) or NaBH4 (peak area (mean±
SD)=8,772±606; n=3) (Fig. S1b, Electronic Supplemen-
tary Material) as reducing agent. However, it is clear that
the use of DTT as reductant results in diminished formation
of labelled gliotoxin (fivefold lower), most likely due to a
reduced rate of disulphide bridge cleavage relative to
NaBH4 and competition with gliotoxin-thiols for reaction
with 5′-IAF. Moreover, residual oxidised gliotoxin (RT=
14.42 min) was present (Fig. S1a, Electronic Supplemen-
tary Material) indicating that DTT is an inferior reductant
compared with NaBH4 for cleavage of the disulphide
bridge on gliotoxin. NaBH4-mediated reduction of glio-
toxin is complete within a maximum of 15 min (mean±
SD=1.5±0.23 μg; n=3), and reduced gliotoxin does not
exhibit any evidence of re-oxidation for up to 2 h post-
reduction (mean±SD=1.5+0.11 μg; n=3). TCEP addition
also resulted in formation of reduced gliotoxin which was
subsequently alkylated with 5′-IAF (data not shown);
however, use of TCEP required reaction pH 7.6 when
gliotoxin modification was undertaken in organic solvents.
No pH adjustment was necessary using NaBH4 under
these conditions.
Assay validation
A calibration curve for gliotoxin detection using
sequential reduction and labelling is shown in Fig. 5,
and a linear response is observed between 0 and
GT-(AF)2
1103.931 A
Fig. 3 MALDI-ToF mass spectrum of GT-(AF)2 (800 fmol) prepared
by reduction and alkylation of gliotoxin. A molecular species of m/z
1103.931 ((M+H)+) is detectable which corresponds precisely to
protonated diacetamidofluorescein–gliotoxin. No product was detect-
able either in the absence of prior reduction or the absence of 5′-IAF
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2,000 pmoL gliotoxin, following RP-HPLC at 254 nm.
The limit of detection for free gliotoxin is 125 pmoL
(40 ng). Intra-assay reproducibility (n=5) was determined
to range between 13% and 14% CV, and interassay
reproducibility (n=5) was calculated to be between 13%
and 16% CV, between for 10–30 nmol gliotoxin
(Table S1). GT-(AF)2 exhibited a mean post-synthesis
stability of 88% during storage at 20–25 °C for 24 h in the
dark. Thus, for long-term storage (up to 1 month) of GT-
(AF)2, −20 °C is recommended.
Reduction and alkylation facilitates detection of gliotoxin
produced by A. fumigatus
To further confirm the utility of the method for gliotoxin
detection, organic extracts from 48-h cultures of A. fumigatus
Af293 were prepared and subjected to reduction and
alkylation with 5′-IAF (Fig. S2, Electronic Supplementary
Material). Although GT-(AF)2 exhibits enhanced absorbance
at 220 versus 254 nm, the majority of analyses were
performed at the latter wavelength to minimise solvent
 Sporidesmin A-(AF)2
A 
B 
C 
D
Fig. 4 RP-HPLC analysis of
pure sporidesmin A A prior to
and B post-sodium borohydride-
mediated reduction prior to 5′-
IAF labelling. C Sporidesmin
A+NaBH4+5′-IAF: disulphide
bridge is reduced and SH groups
(thiols) alkylated by 5′-IAF.
Sporidesmin A-(AF)2 was de-
tectable at 254 nm with a reten-
tion time of 7.96 min. D
Sporidesmin A+5′-IAF: only
free sporidesmin A is present
(7.3 min). Without reduction,
sporidesmin A-(AF)2 is absent. E
MALDI-ToF mass spectrum of
sporidesmin A-(AF)2 prepared
by reduction and alkylation
(530 fmol). A molecular species
of m/z 1251.145 ((M+H)+) is
detectable which corresponds
precisely to protonated diaceta-
midofluorescein–sporidesmin A.
No product was detectable
either in the absence of prior
reduction or the absence of
5′-IAF (data not shown)
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absorbance effects and yield clearer chromatograms. Data
presented in Fig. 6a illustrate that spiked gliotoxin can also be
detected in A. fumigatus culture supernatants without the need
for prior extraction. This strategy required the upward pH
adjustment of culture supernatants (final pH 7.5) and addition
of DMSO to ensure solubility of 5′-IAF during the labelling.
Interestingly, it was noted that use of stock solutions of
NaBH4 (500 mM as opposed to 50 mM) specifically
suppressed the absorbance of unreacted 5′-IAF while that of
GT-(AF)2 was unaffected (Fig. 6b). Detection and quantitation
of native gliotoxin in A. fumigatus culture supernatants (mean
±SD=3.55±0.07 μg/100 μL; n=2), without the need for prior
organic extraction, and organic solvent (DMSO) addition to
reaction mixtures, was also achieved (Fig. 6c). Addition of
lower amounts of 5′-IAF, as a consequence of lower amounts
of endogenous gliotoxin, obviated the requirement to add
DMSO to maintain 5′-IAF solubility. Labelled gliotoxin was
absent without prior reduction (Fig. 6d).
Thin-layer chromatography
Finally, a TLC method for the detection of labelled gliotoxin
has also been developed (Fig. S3, Electronic Supplementary
Material). Solvent optimisation was necessary in order to
achieve the required resolution between GT-(AF)2 and 5′-IAF
(data not shown). The optimal method utilised Merck silica
gel 60-F254 TLC plates (aluminium backed), a dichloro-
methane/methanol/acetic acid (90:10:1) solvent system, can
be completed in 30 min and represents a strategy for high-
throughput, simultaneous analysis of multiple test specimens.
Detection of 150 ng (460 pmoL) GT-(AF)2 was evident, by
fluorescence scanning (sensitivity setting, 600 V), only when
Sporidesmin A-(AF)2
1251.145 
E 
Fig. 4 (continued)
Fig. 5 Calibration curve for gliotoxin detection by sequential
reduction and alkylation (0–2,000 pmoL gliotoxin). Assay conditions
are described in “Materials and methods”, and error bars represent
mean amount±SD (n=3)
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Fig. 6 Optimised RP-HPLC de-
tection of GT-(AF)2 prepared
under aqueous conditions. A
RP-HPLC analysis (method 2)
of culture supernatant (48 h;
adjusted to pH 7.5) of A. fumi-
gatus Af293 strain, spiked with
gliotoxin and following NaBH4
(50 mM) reduction and subse-
quent labelling with 5′-IAF. The
presence of GT-(AF)2 was ob-
served at 15.52 min. B RP-
HPLC analysis of culture super-
natants (48 h; adjusted to
pH 7.5) of A. fumigatus Af293,
spiked with gliotoxin and fol-
lowing NaBH4 (500 mM) re-
duction and subsequent labelling
with 5′-IAF. Gliotoxin
(327 μg mL−1; 50 μL) was
added to 50 μL A. fumigatus
culture supernatant pH 7.5 fol-
lowed by addition of 50 μL
dimethyl sulfoxide. Sodium bo-
rohydride (3.3 μL; 50 or
500 mM) was then added fol-
lowed by 10 μL 5′-IAF
(10 mg mL−1). HPLC injection
volume was 20 μL (equivalent
to 2 μg gliotoxin). C RP-HPLC
analysis (method 3) of culture
supernatants (48 h; adjusted to
pH 7.5) of A. fumigatus Af293
followed reduction and subse-
quent labelling with 5′-IAF. The
presence of GT-(AF)2 (RT,
16.79 min) was observed. D RP-
HPLC analysis, using method 3,
of culture supernatant (48 h;
adjusted to pH 7.5) following
addition of 5′-IAF (20 μL;
3 mg mL−1; 120 nmol), without
prior reduction. No GT-(AF)2
was evident. Free gliotoxin was
observed (RT, 15.49 min). Ab-
sorbance detection at 254 nm
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labelling has been preceded by NaBH4 reduction (Fig. S3,
Electronic Supplementary Material).
Discussion
Improved methods for the sensitive and specific detection of
gliotoxin have been developed. Firstly, it has been shown that
the reducing agent, NaBH4, does not have to be removed
prior to subsequent alkylation of gliotoxin, or sporidesmin A,
thiols using 5′-iodoacetamidofluorescein (5′-IAF). Secondly,
it appears that the resultant diacetamidofluorescein derivative
of gliotoxin (GT-(AF)2) has a higher molar absorption (6.8-
fold) than unlabelled gliotoxin and so, should facilitate
improved detection. Unlike free gliotoxin, the modified form
can be detected by MALDI-ToF MS and has been shown to
exhibit a molecular mass of 1103.93 Da. Our results also
confirm that A. fumigatus-derived gliotoxin in organic
extracts can be identified and that added- and native-
gliotoxin is detectable in pH-adjusted culture supernatants.
In addition, it appears that NaBH4 is a superior gliotoxin-
reducing agent than DTT and that increased amounts of
NaBH4 during modification steps may suppress unreacted 5′-
IAF interference during subsequent RP-HPLC analysis.
Finally, we demonstrate that labelled gliotoxin can also be
detected by TLC.
Conventional RP-HPLC methods, which use UV absor-
bance for detecting gliotoxin, depend solely on the RT of
gliotoxin in test specimens compared with that of a standard
preparation [10, 20]. While this approach is acceptable, the
number of fungal metabolites which can be present in
organic extracts, combined with the possibility of peptide
generation due to unwanted proteolysis, demands a more
rigorous confirmation of gliotoxin presence. LC-MS analysis
of gliotoxin fulfils this criterion; however, this is a relatively
specialised technique and is not available to all researchers
[12, 15, 16]. Moreover, alternative bioassay formats have
also been proposed for detection of gliotoxin and related
epipolythiodioxopiperazines, of fungal origin, at levels of
18–20 ng well−1 [19, 25]. Although the sensitivity of the
Microtox® test is in the low micrograms-per-milliliter-range
[25], the specificity of such tests, which deploy the
sensitivity of bacterial luminescence to mycotoxin presence,
as a measure of gliotoxin presence, is unclear. Sequential
reduction and alkylation of gliotoxin, followed by detection
using RP-HPLC, MALDI-ToF MS, or TLC represents a new
direction for the improved detection of gliotoxin, whereby
the molar absorption of the labelled form is almost sevenfold
greater than free gliotoxin. This observation of enhanced
sensitivity has not been forthcoming from elegant inves-
tigations of glutathione detection following modification
with N-(1-pyrenyl)maleimide and subsequent HPLC identi-
fication of the resultant product [26]. Although GT-(AF)2
was fluorescent, it was observed that fluorescence quench-
ing, under the acidic conditions employed for RP-HPLC
identification, was apparent. Indeed, it has previously been
noted that the quantum yield of fluorescein is significantly
quenched in low pH environments [27] which further
emphasises the practical significance of the enhanced
absorbance of GT-(AF)2 at 220–254 nm.
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NaBH4 reduction of protein disulphides prior to reaction
with 4,4′-dithiodipyridine (Aldrithiol-4®) and subsequent
thiol quantitation by detection of liberated 4-thiopyridone
(A324 nm) has been proposed to enable picomole detection
of total protein thiols [28]. However, this approach required
high temperature incubation (50 °C), addition of hexanol to
prevent foaming during reduction, and destruction of
residual NaBH4 by acidification, prior to 4, 4′-dithiodipyr-
idine addition. The use of NaBH4 for gliotoxin reduction,
which occurs instantaneously at room temperature (20 °C)
requires none of these precautions. In fact, our results
indicate that additional NaBH4 (tenfold) may actually assist
the detection of the di-acetamidofluorescein derivative of
gliotoxin by degrading free 5′-IAF present after reaction. In
addition, the direct detection of the labelled gliotoxin
product confers a degree of specificity not associated with
4-thiopyridone release which is an indirect measure of thiol
presence and could, in theory, result from non-specific
reduction of 4, 4′-dithiodipyridine.
The occurrence of ETP-encoding gene clusters and
studies directed towards elucidation of gliotoxin biosynthe-
sis, and toxicity, are the focus of significant current effort
[1, 2, 23, 29–33]. Thus, the development of a methodology
for the specific detection of gliotoxin, especially under
aqueous conditions and without the requirement for prior
organic extraction and solvent removal, is significant
because it enables direct identification of gliotoxin without
specimen pre-treatment which may otherwise lead to
gliotoxin loss or modification. Moreover, as with alternative
strategies for mycotoxin detection [34], the reductive
alkylation approach developed for detection of gliotoxin
will also be useful in the detection of related ETP toxins
such as sporidesmin A, as we have demonstrated, and other
disulphide- or thiol-containing molecules [35, 36].
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